Last reviewed: May 14, 2026
Last updated: May 14, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
No, Wegovy is not compounded semaglutide—it's an FDA-approved branded injection manufactured by Novo Nordisk. Compounded semaglutide is prepared by licensed 503A pharmacies under specific regulatory conditions. Both medications contain semaglutide as the active ingredient, but they differ significantly in approval status, manufacturing oversight, sourcing, and cost structure.
Understanding these distinctions matters because your treatment plan depends on medical need, provider assessment, insurance coverage, and individual response potential. Genetic factors in your GLP-1 receptor and metabolic pathways may help provide context for how your body processes semaglutide, though these predispositions should be discussed with your qualified healthcare provider.
Regulatory Status: FDA-Approved vs. Compounded Under State Oversight
Wegovy received FDA approval in 2021 for chronic weight management. Its approval process involved extensive clinical trials demonstrating safety and efficacy in large patient populations. The FDA oversees manufacturing at Novo Nordisk's facilities, ensuring batch-to-batch consistency and purity standards through ongoing inspection and testing protocols.
Compounded semaglutide is prepared in licensed 503A pharmacies, which operate under state pharmacy board regulations and federal guidelines. These pharmacies compound semaglutide from pharmaceutical-grade bulk powder under specific conditions—only when an FDA-approved equivalent is unavailable or when a prescriber requests customization. This legal pathway does not imply FDA approval of the compounded product itself.
Key Differences in Source, Cost, and Regulation
The sourcing and regulatory framework between Wegovy and compounded semaglutide create meaningful differences in availability, pricing, and oversight. This comparison helps patients and providers weigh clinical, financial, and access factors when evaluating treatment options together.
| Aspect |
Wegovy (FDA-Approved) |
Compounded Semaglutide (503A Pharmacy) |
| Manufacturer |
Novo Nordisk (branded pharmaceutical) |
Licensed 503A compounding pharmacy |
| Regulatory Approval |
FDA-approved medication |
Compounded under state/federal pharmacy law; not FDA-approved |
| Typical Monthly Cost |
$970–$1,350 (before insurance/copay) |
$149 (PlexusDx pricing range) |
| Manufacturing Oversight |
FDA facility inspections and batch testing |
State pharmacy board oversight and USP standards |
| Prescription Customization |
Fixed pre-filled pen strengths |
Customizable concentrations and formulations available |
Clinical Efficacy: What Evidence Shows About Semaglutide Efficacy Regardless of Source
Clinical trials supporting semaglutide's efficacy used Novo Nordisk's manufactured product. The STEP trials demonstrated approximately 15% average weight loss at the 1.0 mg dose and up to 18% at 2.4 mg over 68 weeks in people with obesity. These data reflect the active ingredient semaglutide's mechanism—GLP-1 receptor agonism—not the manufacturing source.
Individual response to semaglutide varies based on genetics, baseline metabolic health, lifestyle factors, and GLP-1 receptor sensitivity. Your genetic profile in the GLP1R and GIPR genes may help provide context for how your body's receptors respond to semaglutide, though genetics do not determine your exact outcome. A provider should evaluate your candidacy and monitor progress through clinical response, not assumptions.
Who Should Consider Each Option: Safety, Access, and Provider Guidance
Wegovy may be appropriate if you have insurance coverage, prefer established branded products with extensive post-market safety data, or need a specific pre-filled pen design. It is FDA-approved for people with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities. Prior authorization and copay requirements often apply, limiting accessibility for some patients.
Compounded semaglutide from licensed 503A pharmacies may be considered when Wegovy is unavailable, cost-prohibitive, or when a provider determines customized dosing supports your treatment plan. Your healthcare provider must assess your medical history, current medications, and contraindications. Neither option is appropriate without professional medical evaluation and ongoing monitoring for efficacy and side effects.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test examines predispositions in your GLP1R (rs6923761) and GIPR (rs1800437) genes, which code for the receptors where semaglutide acts. These genetic variants may help provide context for how your body's semaglutide sensitivity differs from the general population. Understanding your genetic background should be interpreted with a qualified healthcare provider as one factor among many in treatment planning.
The genetic test also examines FTO (rs9939609) and MC4R (rs17782313) variants linked to metabolic regulation and appetite signaling. These predispositions reveal your baseline genetic architecture in peptide pathways but do not predict your exact response to Wegovy or compounded semaglutide. Genetics influence treatment response likelihood, but lifestyle, adherence, and individual physiology determine real-world outcomes.
By understanding your genetic profile in peptide pathways before starting semaglutide treatment, you and your provider can have a more informed conversation about realistic expectations, monitoring strategies, and whether your genetic predisposition suggests potential sensitivity or resistance patterns. This personalized context may help optimize dosing adjustments and expectations.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as safe as Wegovy?
Licensed 503A pharmacies operate under strict state and federal oversight. Both contain the same active ingredient and mechanism. Safety depends on pharmacy quality standards, your medical history, and provider monitoring. Discuss any concerns with your healthcare provider before starting.
Why is compounded semaglutide so much cheaper than Wegovy?
Compounded semaglutide avoids branded pharmaceutical marketing costs and extensive clinical trial expenses already borne by Novo Nordisk. Lower overhead in compounding allows accessible pricing. Cost difference does not reflect ingredient quality or efficacy of the active agent.
Can PlexusDx genetic testing tell me which—Wegovy or compounded semaglutide—will work better for me?
The Precision Peptide Genetic Test reveals your genetic predispositions in GLP-1 and metabolic pathways but does not predict which branded or compounded formulation will be more effective. Your provider uses genetic context alongside clinical evaluation to optimize treatment strategy.
What should I ask my doctor when deciding between Wegovy and compounded semaglutide?
Ask about insurance coverage, out-of-pocket costs, your medical history and contraindications, monitoring plans, side effect management, and whether your provider has experience with either option. Request discussion of your genetic predispositions if you've had testing.
Do I need a genetic test before choosing between Wegovy and compounded semaglutide?
No—genetic testing is optional and meant to inform discussions with your provider. Your medical evaluation, weight-loss goals, comorbidities, and insurance access are the primary factors. Genetic insights may supplement, not replace, clinical decision-making.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Missed Doses: What Happens If I Miss a Dose of Semaglutide?
Understanding What Are the Doses for Tirzepatide for Effective Weight Management